Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes

BearDownAZ

Sep 13, 2021 09:57AM

Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes

BearDownAZ

Sep 13, 2021 10:00AM

Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes

tada

Sep 13, 2021 10:22PM

Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes

10-41

Sep 14, 2021 12:43AM

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes

in response to

Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes

10-41

posted on Sep 14, 2021 08:16AM

10 - 41 Ya promoting ABL/RVX today should be like selling popsicles on a 100 degree day. For someone who has come from a background of promotion it sure looks like he's lost his touch.